SCHEMBL1633834

SCHEMBL1633834

CCOC(=O)/C(C)=N/Nc1ccc(F)cc1[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 15/20 0.56
MAPK1 P28482 8/20 0.56
LMNA P02545 6/20 0.56
GAA P10253 4/20 0.56
ALDH1A1 P00352 4/20 0.56
TDP1 Q9NUW8 6/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
L3MBTL1 Q9Y468 6/20 0.53
KMT2A Q03164 5/20 0.53
POLB P06746 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 2/20 0.46
PKM P14618 2/20 0.44
NPC1 O15118 1/20 0.44
CRHBP P24387 1/20 0.44
RAB9A P51151 1/20 0.44
CRHR2 Q13324 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1278182 1.00 MAPT (0.56) MAPTMAPK1LMNAGAAALDH1A1
SCHEMBL1278183 1.00 MAPT (0.56) MAPTMAPK1LMNAGAAALDH1A1
SCHEMBL2654183 0.88 MAPT (0.58) MAPTMAPK1LMNAGAAALDH1A1
SCHEMBL13203996 0.88 MAPT (0.58) MAPTMAPK1LMNAGAAALDH1A1
SCHEMBL2654181 0.88 MAPT (0.58) MAPTMAPK1LMNAGAAALDH1A1
SCHEMBL2977194 0.87 MAPT (0.57) MAPTMAPK1LMNAGAAALDH1A1
SCHEMBL2654166 0.87 MAPT (0.57) MAPTMAPK1LMNAGAAALDH1A1
SCHEMBL15468805 0.86 MAPT (0.56) MAPTMAPK1LMNAGAAALDH1A1
SCHEMBL2656855 0.86 MAPT (0.56) MAPTMAPK1LMNAGAAALDH1A1
SCHEMBL13731520 0.86 MAPT (0.56) MAPTMAPK1LMNAGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8309586-B2 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient LG LIFE SCIENCES LTD. (KR) 2012-11-13 US disclosed
US-8309586-B2 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient LG LIFE SCIENCES LTD. (KR) 2012-11-13 US disclosed
US-20120088760-A1 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT LG CHEM, LTD. (KR) 2012-04-12 US disclosed
US-20120088760-A1 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT LG CHEM, LTD. (KR) 2012-04-12 US disclosed
US-20100267708-A1 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT LG LIFE SCIENCES LTD. (KR) 2010-10-21 US disclosed
US-20100267708-A1 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT LG LIFE SCIENCES LTD. (KR) 2010-10-21 US disclosed
WO-2009082152-A2 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT LG LIFE SCIENCES LTD. (KR) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088760-A1 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT GCKR, GCK, GALK1 MAPT 3254/4885MAPK1 579/4885LMNA 3926/4885
US-20100267708-A1 GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT GCK, GCKR, HK1 MAPT 2411/4885MAPK1 596/4885LMNA 4171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.